SEARCH

SEARCH BY CITATION

Abstract

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Acknowledgements
  7. References
  8. Supporting Information

The mechanisms that mediate the initiation and development of intrahepatic cholangiocarcinoma (ICC) associated with hepatitis B and C virus (HBV and HCV, respectively) infection remain largely unclear. In this study we conditionally coexpressed hepatitis B virus X (HBx) and hepatitis C virus core (HCP) proteins in zebrafish livers, which caused fibrosis and consequently contributed to ICC formation at the age of 3 months. Suppressing the transgene expression by doxycycline (Dox) treatment resulted in the loss of ICC formation. The biomarker networks of zebrafish ICC identified by transcriptome sequencing and analysis were also frequently involved in the development of human neoplasms. The profiles of potential biomarker genes of zebrafish ICC were similar to those of human cholangiocarcinoma. Our data also showed that the pSmad3L oncogenic pathway was activated in HBx and HCP-induced ICC and included phosphorylation of p38 mitogen-activated proteinbase (MAPK) and p44/42 mitogen-activated protein kinase (ERK1/2), indicating the association with transforming growth factor beta 1 (TGF-β1) signaling pathway in ICC. Bile duct proliferation, fibrosis, and ICC were markedly reduced by knockdown of TGF-β1 by in vivo morpholinos injections. Conclusion: These results reveal that TGF-β1 plays an important role in HBx- and HCP-induced ICC development. This in vivo model is a potential approach to study the molecular events of fibrosis and ICC occurring in HBV and HCV infection. (HEPATOLOGY 2012;56:2268–2276)

Intrahepatic cholangiocarcinoma (ICC), a highly malignant neoplasm originating from the intrahepatic bile ducts, is the second most common liver cancer worldwide.1 ICC is difficult to diagnose at an early stage, and effective nonsurgical adjuvant therapy has not been developed.

Hepatitis C virus (HCV) is a causative agent of liver diseases. Approximately 3% of the world population is infected with HCV. Although hepatocytes are the major site of HCV replication, several reports have demonstrated that HCV- and HCV-related cirrhosis may be risk factors for ICC.2-4 However, the mechanism by which HCV induces ICC formation is largely unknown. The HCV core protein (HCP) consists of 192 amino acids and modulates multiple cellular processes, including oncogenesis.5

Hepatitis B virus (HBV) infection is a global health problem that afflicts more than 350 million people. Although HBV specifically infects hepatocytes,6 HBV has recently been considered a risk factor for ICC.7 HBV X (HBx) is a 16-kDa protein that has been implicated in the enhancement of viral replication, cell death, lipid metabolism, cell cycle regulation, DNA repair, and epigenetic modification.8-13 HBx is frequently expressed in the tissues surrounding the tumor and may be involved in ICC formation.14 It remains unclear whether the expression of HBx plays a functional role in the pathogenesis of ICC.

Fibrosis, a sign of liver damage, is a predominant feature of hepatobiliary disorder.15 Although several reports have shown that HBx and HCP contribute to fibrogenesis by way of the up-regulation of TGF-β1,16, 17 no animal model has been developed to study the relationship between HBV and HCV and ICC. Previous results have demonstrated that HCP facilitates tumorigenesis in the zebrafish liver.18 Therefore, we investigated whether the coexpression of the HBx and HCP proteins can induce fibrosis and consequently contribute to ICC formation in zebrafish. We established single- and double-transgenic zebrafish lines (expressing one or two viral genes, respectively) and analyzed the histology and gene expression profiles of ICC in these zebrafish.

Materials and Methods

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Acknowledgements
  7. References
  8. Supporting Information

Vector Construction.

The liver-specific tetracycline transactivator (tTA) construct pT2-LF-tTA was generated by modifying the T2KXIGD in plasmid,19 in which L-FABP promoter was used to control the liver specificity20 (Supporting Experimental Procedures).

Microinjection of Zebrafish Embryos and Production of Transgenic Zebrafish Lines.

The transposase messenger RNA (mRNA) and vector were coinjected into embryos and excision efficiency assays were performed as described21 (Supporting Experimental Procedures).

Green Fluorescent Protein (GFP) Induction and Detection.

The embryos derived from the HBx+HCP transgenic lines were maintained in water until 7 days postfertilization (dpf). The larvae were treated with 30 mg/mL Dox for GFP ablation. After induction or ablation, GFP expression was observed under a Zeiss Stemi SV 11 fluorescence microscope (Carl Zeiss, Thornwood, NY) equipped with fluorescence modules (Leica 216 MacroFluo, Heerbrugg, Switzerland) and enhanced filter cubes (Kramer Scientific, Hampton, NJ). Images were taken using a SPOTRT KE color 3-Shot CCD camera photographic system (Diagnostic Instruments, Sterling Heights, MI).

Identification and Mapping of Integration Sites.

The genomic DNA was isolated from F5 transgenic line. The 3′ flanking fragment of expression cassettes were cloned and sequenced (Supporting Experimental Procedures).

Transcriptome Sequencing and Analysis.

Total RNA was purified from a pool of partial liver of three fish from each transgenic zebrafish line (WT, HBx, HCP, and HBx+HCP) and sequenced using the SOLiD System 3.0 (Applied Biosystems, Foster City, CA). The primary analysis was performed using the SOLiD Analysis Tool Pipeline (Applied Biosystems). The data were expressed as log2-fold changes of gene expression. The gene ontology was categorized using MetaCore software (GeneGo). The log2-fold change of gene expression was determined by comparing the RPKM values of the HBx+HCP and HCP transgenic zebrafish.

Quantitative Reverse-Transcription Polymerase Chain Reaction (RT-PCR).

Total RNA from fish liver tissue was purified and reverse transcribed to complementary DNA (cDNA). Quantitative RT-PCR was performed using Roche LightCycler 480 Real-Time PCR System (Supporting Experimental Procedures). The primer sequences are listed in Supporting Table S1.

Whole-Mount In Situ Hybridization.

Sense and antisense digoxigenin probes for HBx and HCP were generated by in vitro transcription using T7 or SP6 RNA polymerase as described.22

Histologic and Immunohistochemical Studies.

Liver tissues were fixed with 10% formalin and embedded in paraffin. The 4-5-μm thick sections were cut and stained with hematoxylin and eosin (H&E) for histologic examinations. For immunohistochemical study, the antibodies included anti-TGF-β1 (AnaSpec, Fremont, CA), anti-p-38 (1:50), anti-p-ERK1/2 (Thr202/Tyr204, 1:100) (Cell Signaling Technology, Danvers, MA), anti-pSmad3L (1:200, Immuno-Biological Laboratories), anti-CK18 (cytokeratin 18; 1 μg/mL, Lifespan Biosciences), anti-α-SMA (alpha smooth muscle actin; 1:200), and anti-PCNA (proliferating cell nuclear antigen; 1:1,000, Abcam, Cambridge, MA).

Terminal Transferase dUTP Nick End-Labeling (TUNEL) Assay.

The 4-5-μm thick liver sections were labeled with fluorescein-dUTP and apoptotic cells were detected using in situ cell death detection kit (Roche Applied Science).

Immunofluorescence Assay.

Fresh liver tissues were embedded in OCT medium and stored at −20°C until use. Ten-μm thick frozen sections were labeled with anti-zebrafish gut secretory cell epitopes antibody (1:200, FIS 2F11/2, Abcam, Cambridge, MA) and counterstained with DAPI (4′, 6-diamidino-2-phenylindole) solution. Images were taken using a Leica TCS SP5 MP microscope system.

Mason's Trichrome and Sirius Red Staining.

Five-mm-thick formalin-fixed, paraffin-embedded sections were used for Mason's trichrome and Sirius red stains using commercial kits (Sigma Aldrich, St. Louis, MO).

In Vivo Morpholino (MO) Knockdown.

Twenty 2-month-old F4 HBx+HCP transgenic zebrafish were intraperitoneally injected with Vivo-MO twice per week for 1 month.23 Partial liver samples were obtained for further gene expression analysis (Supporting Experimental Procedures).

Western Blotting.

Protein was isolated from liver tissues obtained from 3-month-old morphants. Western blotting was performed using a standard protocol (Supplementary Experimental Procedures).

Results

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Acknowledgements
  7. References
  8. Supporting Information

Generation of Liver-Specific Tet-Off Transgenic Zebrafish Lines.

To establish inducible viral transgenes in zebrafish lines, we microinjected wildtype (WT) zebrafish embryos with four sets of two separate plasmids as following: HBx line, pT2-LF-tTA and pT2-GFP-BI-HBx; HCP line, pT2-LF-tTA and pT2GFP-BI-HCP; HBx+HCP transgenic line, pT2-LF-tTA, pT2-HcRed-BI-HBx, and pT2-GFP-BI-HCP; and vector control (CT), pT2-LF-tTA and pT2-GFP-BI (Supporting Fig. S1A). We generated CT (Tg(LFABP:tTA; TRE-CMV:GFP)), HBx alone (Tg(LFABP:tTA; TRE-CMV:GFP; TRE-CMV:HBx)), HCP alone (Tg(LFABP:tTA; TRE-CMV:GFP; TRE-CMV:HCP)), and HBx+HCP (Tg(LFABP:tTA; TRE-CMV:GFP; TRE-CMV:HcRed; TRE-CMV:HBx; TRE-CMV:HCP)) transgenic zebrafish lines. The stable expression of transgenes in each line was confirmed by fluorescent imaging (Fig. 1A; Supporting Fig. S1B) and RT-PCR (Supporting Fig. S1C). We performed whole-mount in situ hybridization to further confirm the expression of HBx and HCP in transgenic zebrafish liver. In Fig. 1B, HBx was specifically expressed in HBx and HBx+HCP fish livers (left panel). The HCP and HBx+HCP fish livers were labeled with the HCP probe (Fig. 1B, right panels). No signals were detected either in HBx+HCP line with sense probes or in HCP line with HBx-AS probe and HBx line with HCP-AS probe (Supporting Fig. S2). These results revealed that HBx and HCP are specifically expressed in transgenic fish livers. We then performed immunofluorescent assays to examine the specificity of the L-FABP promoter. In the liver of CT zebrafish, L-FABP-driven GFP was not localized in the bile duct cells expressing 2F11/2 protein (red fluorescence) (Supporting Fig. S3). To identify the integration locus, we sequenced the 3′ flanking fragment of expression cassettes in HBx, HCP, and HBx+HCP lines. The results showed that only tTA cassette inserted in the exon of a predicted gene (LOC100150696 similar to Zinc finger protein 264) in HBx line (Table S2). The other 10 integration loci of cassettes are not tagged genes or intron of genes.

thumbnail image

Figure 1. Liver-specific inducible transgenic zebrafish. (A) Fluorescence photomicrograph of 3-month-old HBx+HCP zebrafish. (B) Whole-mount in situ hybridization of 5 dpf zebrafish lines with HBx and HCP antisense probes (HBx-AS and HCP-AS, respectively).

Download figure to PowerPoint

Induction of ICC in the Livers of HBx+HCP Transgenic Zebrafish.

Histologically, the livers of F3 HBx+HCP transgenic zebrafish exhibited several morphologic alternations including cytoplasmic vacuolation (Fig. 2A, left panel), bile duct dilation (Fig. 2A, middle panel), and fibrosis (Fig. 2A, right panel) as early as 1 month of age. In 3-month-old HBx+HCP zebrafish, some of the fluorescent areas in the liver were no longer present (Supporting Fig. S4). The liver of HBx+HCP zebrafish lines was almost replaced by ICC composed of proliferation and infiltration of irregularly shaped and variably sized neoplastic glands surrounded by a dense fibrous stroma (Fig. 2B). In contrast, none of the zebrafish carrying a single viral gene or the vector had ICC formation (Supporting Fig. S5). At 1 month, 25% of the HBx+HCP zebrafish exhibited fibrosis. This percentage increased to 45% at 3 months and included 35% of zebrafish with early and severe ICC (Table 1). Both Masson's trichrome and Sirius red stains revealed fibrosis in HBx+HCP transgenic zebrafish (Fig. 3A,B), whereas as no fibrosis was observed in the liver of HBx, HCP, CT, and WT zebrafish lines (Fig. 3C-F, respectively).

thumbnail image

Figure 2. Histological examination of ICC induced by the coexpression of HBx and HCP. (A) Vacuolated cytoplasm (left panel), bile duct cell hyperplasia (middle panel), and fibrosis (right panel) were detected in the liver of 1-month-old HBx+HCP zebrafish. ICC was detected in the zebrafish liver at 3 months of age (B). The arrow indicates the bile duct.

Download figure to PowerPoint

thumbnail image

Figure 3. Fibrosis demonstrated by Mason's trichrome (blue) and Sirius red (red) stains in all zebrafish lines. Liver of HBx+HCP zebrafish showing prominent fibrosis by Masson's trichrome (A) and Sirius red (B) stains. Absence of fibrosis in the liver of (C) HBx, (D) HCP, (E) CT, and (F) WT zebrafish.

Download figure to PowerPoint

Table 1. Histological Subject Characteristics
 HBx+HCPHBxHCPControlWT
Age (month)1233333
  • The sample size of each group is 20.

  • The extent of involved area is less than 50% of total areas (early ICC). In most severe cases, the entire liver was nearly replaced by proliferating neoplastic bile ducts (severe ICC).

  • *

    Early ICC;

  • 20% early ICC and 15% severe ICC.

Unremarkable65%65%25%100%100%100%100%
Bile duct dilation15%20%30%0%0%0%0%
Bile duct proliferation30%15%45%0%0%0%0%
Bile duct fibrosis25%20%45%0%0%0%0%
ICC10%*15%*35%0%0%0%0%

To confirm that these phenotypes were induced by the transgenes, we turned off transgenes expression using 30 μg/mL Dox treatment. No significant phenotype was observed in the liver of Dox-treated HBx+HCP transgenic zebrafish at 1.5 or 3 months (Supporting Figs. S3B, S6A). Furthermore, fibrosis and ICC were induced in the liver of 4.5-month-old HBx+HCP zebrafish after inducing transgene expression at 1.5 months of age (Supporting Fig. S6C).

We then performed immunohistochemistry (IHC) and TUNEL assays to examine the fate of the tumor cells. Using an antibody against PCNA, we found that liver of HBx+HCP zebrafish with dilated bile ducts showing increased proliferation (Supporting Fig. S7C), whereas ICC showing a very high proliferation index (Supporting Fig. S7D). In contrast, liver of HBx and HCP zebrafish showing a very low proliferation index (Supporting Fig. S7A,B). We examined the apoptotic events in the liver using the TUNEL assay. Compared with the HBx and HCP fish, DNA strand breaks were detected in the tissues surrounding the abnormal bile ducts in the livers of HBx+HCP fish (Supporting Fig. S8).

Gene Expression Analysis of ICC.

To analyze the biological significance of regulatory pathways involved in viral protein-induced ICC, we investigated the global gene expression in liver samples from each zebrafish line to define common and differential gene expression signatures and dysregulated genes. We sequenced mRNA purified from the livers of WT, single-transgenic zebrafish, and tumor samples of double-transgenic zebrafish. We identified 75-102 million 50-bp sequence reads per sample (GEO database; accession number GSE34493). Approximately 34-44 million reads could be mapped onto the zebrafish genome (Supporting Table S4), and these reads were analyzed to obtain the differential expression data for the transgenic zebrafish liver samples using enrichment analysis with MetaCore. The data for the ICC samples were compared with those for the HCP samples (Supporting Table S5). The results show that the different gene expression profiles in the ICC include genes involved in cytoskeletal remodeling, cell adhesion, development, and cell cycle regulation among the top 10 GeneGo pathways (Fig. 4A). The different expression profiles of genes are related to cell cycle processes, development, proteolysis, immune responses, and transcription among the top 10 GeneGo process networks (Fig. 4B). Furthermore, the expression profiles were consistent with genes involved in regulating several types of neoplasms among the top 10 GeneGo biomarker networks (Fig. 4C). The quantitative features of the potential cholangiocarcinoma marker genes in zebrafish were consistent with those in humans (Table 2).

thumbnail image

Figure 4. The top-ranked up-regulated genes more than 2-fold and down-regulated genes more than 0.5-fold changes identified by differential expression analysis followed by pathway analysis (MetaCore). (A) GeneGo pathway maps, (B) GeneGo process network, and (C) GeneGo disease biomarker networks.

Download figure to PowerPoint

Table 2. Conserved Quantitative Features of Potential Cholangiocarcinoma Marker Genes Between Zebrafish and Human
EntrezGene IDs from ZebrafishEntrezGene IDs from HumanGene SymbolGene NameGene SynonymsRPKM Value in Zebrafish ICCExpression Change in Zebrafish ICC (log2 ratio)qRT-PCR (log2 ratio)Reference (PubMed ID)
  • *

    It is uniquely up-regulated in zebrafish ICC.

  • Those genes are up-regulated in human cholangiocarcinoma samples.

565373375790AGRNagrinagrin proteoglycan4.636up (2.21)4.3917640714
30222595CCND1cyclin D1G1/S-specific cyclin D10.064up (4.0)6.1616142313
3937751191CLU*clusterintestosterone-repressed prostate message 20.674up (2.63)1.6515897574
1144477852CXCR4*chemokine (C-X-C motif) receptor 4leukocyte-derived seven transmembrane domain receptor0.537up (2.28)5.0916565491
3784781956EGFR*epidermal growth factor receptorreceptor tyrosine-protein kinase erbB-10.219up (2.1)0.7815519654; 16032426; 18087285
39324951280GOLM1golgi membrane protein 1Golgi membrane protein 14.605up (1.58)4.0719291786
36891155353LAPTM4Blysosomal protein transmembrane 4 betalysosome-associated transmembrane protein 4-beta8.397up (4.21)3.7218334282
3070151176LEF1lymphoid enhancer-binding factor 1T cell-specific transcription factor 1-alpha0.275up (3.85)9.8811557787
3731024170MCL1*myeloid cell leukemia sequence 1 (BCL2-related)bcl-2-related protein EAT/mcl187.217up (3.32)3.5515940637
1001506644233MET*met proto-oncogene (hepatocyte growth factor receptor)HGF/SF receptor0.428up (1.15)3.8011895493
4063974318MMP9*matrix metallopeptidase 9matrix metalloproteinase-90.143up (1.95)2.6019218340
5590205743PTGS2prostaglandin-endoperoxide synthase 2prostaglandin G/H synthase 20.176up (6.46)6.2817165088
7965517015TERT*telomerase reverse transcriptasetelomerase-associated protein 20.742up (2.12)1.5516237755
305907157TP53tumor protein p53p53 tumor suppressor5.643up (1.76)1.4020668938
815407298TYMSthymidylate synthetasethymidylate synthase2.796up (3.51)2.7820880064
5581547422VEGFA*vascular endothelial growth factor Avascular endothelial growth factor44.551up (2.63)4.5018087285
302651499CTNNB1catenin (cadherin-associated protein), beta 1, 88kDacatenin beta-132.766up (2.68)4.4616142313

JNK/pSmad3L Oncogenic Pathway Activation in ICC.

TGF-β-dependent JNK/pSmad3L oncogenic pathway activation has been observed in rat hepatic stellate cells and myofibroblasts after liver injury.24, 25 The status of the TGF-β-dependent JNK/pSmad3L oncogenic pathway can be used to evaluate the risk for developing hepatocellular carcinoma (HCC) in HBV-infected patients.26 Based on the results of the gene expression analysis, TGF-β-dependent epithelial-mesenchymal transition (EMT) and cell proliferation occurred among the top 10 rankings (Fig. 4A). To identify the TGF-β-dependent JNK/pSmad3L oncogenic pathway that might be responsible for cholangiocarcinogenesis, we evaluated the expression of TGF-β1- and pSmad3L-related genes using qRT-PCR and compared these data to the transcriptome sequencing data. The results demonstrated that all of the selected genes (tgfb1, smad2, smad3, p38, erk1, kras, ctgf, ccnd1, and vegfa) were up-regulated in ICC samples (Supporting Fig. S9). The analysis of the TGF-β1 expression revealed that the liver exhibited a robust TGF-β1 signal in HBx+HCP zebrafish liver (Fig. 5). In Fig. 5, fibrosis was further confirmed by evaluating the expression for α-SMA (marker for activated stellate cells), HBx+HCP liver revealed higher levels of expression in ICC when compared with HBx fish (HBx+HCP, Fig. 5; HBx, Supporting Fig. S10). No α-SMA was detected in HCP fish liver (Supporting Fig. S10). We then investigated the phosphorylation level and localizations of pp38, pERK1/2, and pSmad3L, which are downstream of TGF-β1, during HBx- and HCP-induced cholangiocarcinogenesis in HBx+HCP zebrafish livers. As shown in Fig. 5, high level of pp38, pERK1/2, and pSmad3L were detected in the nuclei of cholangiocytes, which are neoplastic bile duct epithelial cells. In contrast, less of the phosphorylated proteins were detected in the livers isolated from HBx or HCP transgenic zebrafish (pp38, Supporting Fig. S10; pERK1/2 and pSmad3L, Supporting Fig. S11). ICC isolated from HBx+HCP zebrafish livers were strongly positive for CK18 (bile duct cell marker in zebrafish)27 labeling using IHC compared with HBx or HCP zebrafish livers (HBx+HCP, Fig. 5; HBx or HCP, Supporting Fig. S11).

thumbnail image

Figure 5. Activation of the pSmad3L oncogenic pathway in ICC. Tumor surrounding tissue of liver showing intense TGF-β1 immunostaining in HBx+HCP zebrafish. ICC showing intense α-SMA immunostaining in the stroma in HBx+HCP fish liver. We detected phosphorylated p38 (pp38) and phosphorylated ERK1/2 (pERK1/2) in the nuclei of tumor cells and phosphorylated Smad3L (pSmad3L) in the tumor. ICC showing intense CK 18 immunostaining in HBx+HCP fish liver. Arrow indicates the bile duct.

Download figure to PowerPoint

Reduced Fibrosis and ICC by TGF-β1 Knockdown.

To determine whether TGF-β1 plays a role in bile duct neoplasms, we intraperitoneally injected tgfb1-MO into 2-month-old zebrafish twice per week. The correlation between tgfb1-MO administration and phenotypes was evaluated using the chi-squared test. The results showed that the percentage of zebrafish with bile duct proliferation, fibrosis, and ICC was significantly reduced after injection for 1 month (Table 3). The suppressed expression of tgfb1 in 3-month-old morphants was further confirmed using RT-PCR (Supporting Fig. S12A). The TGF-β1 downstream proteins, including phosphorylated p38, ERK1/2, and Smad3L were decreased in MO-injected zebrafish livers (Supporting Fig. S12B). At the RNA level, only tgfb1 and mmp9 were significantly decreased in tgfb1 morphants (Supporting Fig. S12C). These results indicate the down-regulation of protein phosphorylation by TGF-β1 knockdown.

Table 3. Histological Subject Characteristics of Morphants
 Control MO (n = 17)TGF-β1 MO (n = 19)P-value
  • Chi-square was used to determine the relationship between TGF-β1 and each phenotype with unremarkable.

  • The criteria of early and severe ICC are the same as defined in Table 1.

  • *

    12% early ICC and 17% severe ICC;

  • early ICC.

Unremarkable35%58% 
Bile duct dilation12%16%0.021
Bile duct proliferation53%32%0.009
Bile duct fibrosis53%32%0.009
ICC29%*11%0.001

Discussion

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Acknowledgements
  7. References
  8. Supporting Information

Zebrafish are an ideal model for studying embryonic development because their transparency allows one to observe their dynamic physiology in a noninvasive manner.28 Additionally, zebrafish are a good animal model for studying human diseases due to their ability to produce pathological phenotypes comparable to those in humans.29, 30 For instance, a zebrafish carcinogen-induced liver tumor displays a transcriptome profile comparable to that of human liver cancer. This conservation emphasizes the potential of zebrafish as a model for liver cancer research.31 Although evidence linking HBV and HCV infection to ICC development is based on statistical analyses of patient samples,2, 7 the mechanisms by which HBV and HCV mediate ICC development remain largely unknown. In this study, our transgenic zebrafish model is the first to provide correlative evidence that ICC can be induced by the coexpression of HBx and HCP. We substantiated this conclusion by repressing or reinducing transgenes in the adult liver using Dox treatment. ICC of this model displays the histopathologic characteristics that are highly identical to human ICC as well as the molecular features of human diseases, including the neoplasm networks and potential biomarkers.

The direct oncogenic role of HBx in liver cancer is controversial. The first HBx transgenic mice were generated using a microinjected embryo of ICR (CD-1) and B6C3F1 mice to promote mild liver diseases.32 However, several studies have revealed normal livers in HBx transgenic mice.33-36 In contrast, HBx induces liver cancer in CD-1 mice.37 CD-1 mice are susceptible to spontaneous HCC development.38 Other HBx transgenic mice display a phenotype in the presence of a carcinogen.39-42 The aforementioned studies indicated an indirect role for HBx in oncogenesis. However, several studies have supported a direct oncogenic role for HBx in liver cancer.43, 44 In the current study, coexpression of HBx and HCP induced ICC in transgenic zebrafish. In contrast, HBx alone failed to induce ICC, indicating an indirect oncogenic role in the zebrafish model.

Tumor stroma provides the microenvironment necessary for cancer growth.45 TGF-β is one of the cancer-derived cytokines that drive the conversion of normal fibroblasts into cancer-associated fibroblasts. A previous study demonstrated that HBx induces TGF-β secretion from hepatocytes and activates hepatic stellate cells (HSCs) to promote collagen secretion. These data suggest a role for HBx in HBV-related liver fibrosis.17 In this model, TGF-β1 and connective tissue growth factor (CTGF) were highly expressed in the HBx+HCP zebrafish livers. In addition, we detected collagen fiber and α-SMA accumulation around abnormal bile ducts. Several TGF-β-dependent pathways were ranked among the top 10 pathways using MetaCore software. In the HBx+HCP zebrafish livers, TGF-β1 was detected in the tissues surrounding the tumor that indicate the involvement of TGF-β1 in HBx- and HCP-induced stroma. To elucidate the molecular mechanisms involved in HBx- and HCP-induced ICC, we suppressed tgfb1 expression. We showed that fibrosis and ICC formation as well as decreased pSmad3L signaling were markedly reduced by knockdown of TGF-β1 by in vivo MO injections. Therefore, our results indicate the requirement of TGF-β1 in HBx- and HCP-induced ICC.

More severe liver diseases have been identified in patients with coinfections of HBV and HCV,46, 47 although another study reported interference between HBV and HCV.48 In contrast, a previous study using an in vitro system has shown that the replication of both viruses proceeded without interference.49 Moreover, HBx increased liver pathogenesis in HCV transgenic mice by causing an imbalance between hepatocyte death and regeneration within the context of severe steatosis.50 HBx and HCP significantly reduced the sensitivity to reactive oxygen species (ROS)-induced cell death and induced survival benefits in HepG2 cells.51 Our results show that the ICC induced by coexpression of HBx and HCP are histologically and genetically similar to their human counterparts, thus supporting the synergistic role of both viruses in the development of liver disease. Collectively, this study demonstrates the potential of this zebrafish model to study HBV- and HCV-induced fibrosis and bile duct neoplasms.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Acknowledgements
  7. References
  8. Supporting Information

The authors thank the Core Facility of the ICOB, Academia Sinica, and the Taiwan Mouse Clinic for technical support. The authors also thank the Taiwan Zebrafish Core Facility at Academia Sinica (ZCAS) for providing AB wildtype fish.

References

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Acknowledgements
  7. References
  8. Supporting Information
  • 1
    Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2012; 9: 44-54.
  • 2
    Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12: 959-964.
  • 3
    Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004; 95: 592-595.
  • 4
    Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88: 2471-2477.
  • 5
    Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-1067.
  • 6
    Sureau C, Romet-Lemonne JL, Mullins JI, Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 1986; 47: 37-47.
  • 7
    Fwu CW, Chien YC, You SL, Nelson KE, Kirk GD, Kuo HS, et al. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan. HEPATOLOGY 2011; 53: 1217-1225.
  • 8
    Keasler VV, Hodgson AJ, Madden CR, Slagle BL. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 2007; 81: 2656-2662.
  • 9
    Hu L, Chen L, Yang G, Li L, Sun H, Chang Y, et al. HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade. Mol Cancer 2011; 10: 43.
  • 10
    Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007; 132: 1955-1967.
  • 11
    Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A 1995; 92: 11215-11219.
  • 12
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007; 132: 1476-1494.
  • 13
    Jia L, Wang XW, Harris CC. Hepatitis B virus X protein inhibits nucleotide excision repair. Int J Cancer 1999; 80: 875-879.
  • 14
    Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 1998; 4: 392-396.
  • 15
    Abou-Shady M, Friess H, Zimmermann A, di Mola FF, Guo XZ, Baer HU, et al. Connective tissue growth factor in human liver cirrhosis. Liver 2000; 20: 296-304.
  • 16
    Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, et al. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 2005; 37: 138-145.
  • 17
    Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, Molina-Jimenez F, Lopez-Cabrera M, et al. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. HEPATOLOGY 2008; 47: 1872-1883.
  • 18
    Rekha RD, Amali AA, Her GM, Yeh YH, Gong HY, Hu SY, et al. Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology 2008; 243: 11-22.
  • 19
    Urasaki A, Morvan G, Kawakami K. Functional dissection of the Tol2 transposable element identified the minimal cis-sequence and a highly repetitive sequence in the subterminal region essential for transposition. Genetics 2006; 174: 639-649.
  • 20
    Her GM, Chiang CC, Chen WY, Wu JL. In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio). FEBS Lett 2003; 538: 125-133.
  • 21
    Kawakami K. Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element. Methods Cell Biol 2004; 77: 201-222.
  • 22
    Alexander J, Rothenberg M, Henry GL, Stainier DY. Casanova plays an early and essential role in endoderm formation in zebrafish. Dev Biol 1999; 215: 343-357.
  • 23
    Notch EG, Shaw JR, Coutermarsh BA, Dzioba M, Stanton BA. Morpholino gene knockdown in adult Fundulus heteroclitus: role of SGK1 in seawater acclimation. PLoS ONE 2011; 6: e29462.
  • 24
    Yoshida K, Matsuzaki K, Mori S, Tahashi Y, Yamagata H, Furukawa F, et al. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol 2005; 166: 1029-1039.
  • 25
    Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. HEPATOLOGY 2003; 38: 879-889.
  • 26
    Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, et al. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. HEPATOLOGY 2009; 49: 1203-1217.
  • 27
    Lorent K, Yeo SY, Oda T, Chandrasekharappa S, Chitnis A, Matthews RP, et al. Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy. Development 2004; 131: 5753-5766.
  • 28
    Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A 2007; 104: 17406-17411.
  • 29
    Feitsma H, Cuppen E. Zebrafish as a cancer model. Mol Cancer Res 2008; 6: 685-694.
  • 30
    Kari G, Rodeck U, Dicker AP. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther 2007; 82: 70-80.
  • 31
    Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, Tong Y, et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 2006; 24: 73-75.
  • 32
    Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SL, Butel JS. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 1990; 64: 5939-5947.
  • 33
    Reifenberg K, Lohler J, Pudollek HP, Schmitteckert E, Spindler G, Kock J, et al. Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice. J Hepatol 1997; 26: 119-130.
  • 34
    Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P, et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997; 14: 395-404.
  • 35
    Madden CR, Finegold MJ, Slagle BL. Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol 2000; 74: 5266-5272.
  • 36
    Zhu HZ, Cheng GX, Chen JQ, Kuang SY, Cheng Y, Zhang XL, et al. Preliminary study on the production of transgenic mice harboring hepatitis B virus X gene. World J Gastroenterol 1998; 4: 536-539.
  • 37
    Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320.
  • 38
    Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
  • 39
    Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 1996; 15: 261-269.
  • 40
    Madden CR, Finegold MJ, Slagle BL. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol 2001; 75: 3851-3858.
  • 41
    Madden CR, Finegold MJ, Slagle BL. Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol 2002; 76: 11770-11774.
  • 42
    Zhu H, Wang Y, Chen J, Cheng G, Xue J. Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis. Exp Mol Pathol 2004; 76: 44-50.
  • 43
    Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, et al. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. HEPATOLOGY 1994; 19: 810-819.
  • 44
    Koike K, Moriya K, Yotsuyanagi H, Iino S, Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 1994; 94: 44-49.
  • 45
    Liao D, Luo Y, Markowitz D, Xiang R, Reisfeld RA. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS One 2009; 4: e7965.
  • 46
    Lee LP, Dai CY, Chuang WL, Chang WY, Hou NJ, Hsieh MY, et al. Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients. J Gastroenterol Hepatol 2007; 22: 515-517.
  • 47
    Sagnelli E, Pasquale G, Coppola N, Scarano F, Marrocco C, Scolastico C, et al. Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection 2004; 32: 144-148.
  • 48
    Chen SY, Kao CF, Chen CM, Shih CM, Hsu MJ, Chao CH, et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003; 278: 591-607.
  • 49
    Bellecave P, Gouttenoire J, Gajer M, Brass V, Koutsoudakis G, Blum HE, et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. HEPATOLOGY 2009; 50: 46-55.
  • 50
    Keasler VV, Lerat H, Madden CR, Finegold MJ, McGarvey MJ, Mohammed EMA, et al. Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology 2006; 347: 466-475.
  • 51
    Severi T, Vander Borght S, Libbrecht L, VanAelst L, Nevens F, Roskams T, et al. HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. Chem Biol Interact 2007; 168: 128-134.

Supporting Information

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Acknowledgements
  7. References
  8. Supporting Information

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
HEP_25914_sm_SuppFig1.tif4745KSupporting Information Figure 1. Figure S1. Liver-specific inducible transgenic zebrafish. A, The liver-specific activator plasmid pT2-LF-tTA (a) containing an activator (tTA) driven by a zebrafish L-FABP promoter, and the tetracycline-responsive plasmids pT2-GFP-BI-HCP, pT2-GFP-BI-HBx, pT2-HcRed-BI-HBx, and pT2-GFP-BI (b-e, respectively) containing genes driven by a Tet-controlled bidirectional promoter, are illustrated. All expression cassettes were flanked by the Tol2 transposon. B, Fluorescence photomicrograph of 3-month-old transgenic zebrafish. C, The amount of viral mRNA in individual samples was estimated using RT-PCR with the HBx and HCP primers.
HEP_25914_sm_SuppFig2.tif3021KSupporting Information Figure 2. Whole mount in situ hybridization of 5 dpf zebrafish lines with HBx and HCP antisense probes (HBx-AS and HCP-AS, respectively; sense probe HBx-S and HCP-S as control). No signal was observed in HCP and HBx with HBx-AS and HCP-AS, respectively.
HEP_25914_sm_SuppFig3.tif1649KSupporting Information Figure 3. Immunofluorescence assay of CT zebrafish. The bile duct and nucleus of CT liver showed positive staining for 2F11/2 (red) and DAPI (blue), respectively. GFP (green) was not localized in the 2F11/2-positive cells.
HEP_25914_sm_SuppFig4.tif3976KSupporting Information Figure 4. Gross and fluorescent morphology of 3-month-old HBx+HCP zebrafish. ICC in HBx+HCP zebrafish displayed darkly pigmented regions (A) without a fluorescence signal (B) within the liver compared with a CT fish liver (C and D).
HEP_25914_sm_SuppFig5.tif3049KSupporting Information Figure 5. Figure S5. Histological examination of transgenic zebrafish livers. None of the zebrafish carrying a single viral gene or the vector had ICC formation at 3 months of age. The arrow indicates the bile duct.
HEP_25914_sm_SuppFig6.tif2541KSupporting Information Figure 6. Figure S6. Histological examination of ICC that was induced by conditional co-expression of HBx and HCP. Liver of HBx+HCP transgenic zebrafish with 3 (A) and 1.5 (B) months of Dox treatment showing no obvious alterations. (C) zebrafish subjected to 3 month-withdrawal showing ICC formation.
HEP_25914_sm_SuppFig7.tif3943KSupporting Information Figure 7. Figure S7. Evaluation of proliferation by PCNA immunostaining in the liver of transgenic zebrafish lines. Liver of HBx (A) and HCP (B) zebrafish showing a very low proliferation index. Liver of HBx and HCP zebrafish with dilated bile ducts showing increased proliferation (C), whereas ICC showing a very high proliferation index (D).
HEP_25914_sm_SuppFig8.tif3882KSupporting Information Figure 8. Figure S8. Immunohistochemical in situ TUNEL detection of apoptosis in zebrafish liver. Liver of HBx (A) and HCP (B) zebrafish showing a low DNA damage. Liver of HBx and HCP zebrafish with dilated bile ducts showing a low DNA damage (C), whereas ICC showing a high DNA strand breaks in the tissues surrounding the abnormal bile ducts (D).
HEP_25914_sm_SuppFig9.tif1900KSupporting Information Figure 9. Figure S9. Co-expression of HBx and HCP increased the expression of pSmad3L oncogenic pathway-related genes. The expression levels of the TGF-?1- and pSmad3L-related genes (tgfb1, smad2, smad3, p38, erk1, kras, ctgf, ccnd1, and vegfa) involved in ICC formation were examined using quantitative RT-PCR and transcriptome sequencing (RNAseq) in 3-month-old zebrafish livers. The expression level of gapdh served as an internal control. The qRT-PCR experiment was performed in biological triplicate. The error bars indicate the S.D.
HEP_25914_sm_SuppFig10.tif4397KSupporting Information Figure 10. Figure S10. Immunohistochemistry of HBx and HCP transgenic zebrafish liver for TGF-?1, ?-SMA, and pp38. Weak TGF-?1 was detected in the livers isolated from HBx or HCP transgenic zebrafish. The liver tissue showing ?-SMA immunostaining surround the bile duct in HBx zebrafish. The liver tissue showing weak immunostaining of phosphorylated p38 (pp38) in HBx or HCP transgenic zebrafish. Arrow indicates the bile duct.
HEP_25914_sm_SuppFig11.tif4405KSupporting Information Figure 11. Figure S11. Immunohistochemistry of HBx and HCP transgenic zebrafish liver for pERK1/2, pSmad3L, and CK18. Weak pERK1/2, pSmad3L, and CK18 were detected in the livers isolated from HBx or HCP transgenic zebrafish. Arrow indicates the bile duct.
HEP_25914_sm_SuppFig12.tif801KSupporting Information Figure 12. Figure S12. Injection of tgfb1-MO suppressed the pSmad3L oncogenic pathways in the liver of HBx+HCP zebrafish. A, RT-PCR was performed to confirm that tgfb1 expression was suppressed in morphants. B, The liver samples of the 3-month-old morphants were immunoblotted with antibodies against TGF-?1, phospho-Smad3L, phospho-p38, phospho-ERK1/2, and GAPDH (internal control). C, The expression levels of the TGF-?1-related genes (tgfb1, smad2, smad3, p38, and jnk) and pSmad3L downstream gene (mmp9) were examined using quantitative RT-PCR in the liver of tgfb1 morphants. *, p < 0.05, t test. The error bars indicate the S.D.
HEP_25914_sm_SuppTab1to4.doc95KSupporting Information Table 1 to 4.
HEP_25914_sm_SuppTab5.xls7605KSupporting Information Table 5. The differential expression data of transgenic zebrafish samples (continue).
HEP_25914_sm_SuppTab6.xls251KSupporting Information Table 6. The gene list of the top-ranked up-regulated genes more than 2-fold and down-regulated genes more than 0.5-fold changes identified by differential expression analysis followed by pathway analysis (MetaCore).
HEP_25914_sm_SuppInfo.doc44KSupporting Information

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.